Clinical Trials Logo
  1. Home
  2. Head & Neck Cancer
  3. NCT03157674

Real-World Evidence and Treatment Patterns: Head and Neck Cancer

Head & Neck Cancer Clinical Trial

Official title:
Real-World Evidence and Treatment Patterns: Head and Neck Cancer

Clinical Trial Summary

This study will be focused on HNC patients who have been diagnosed with HNC between 01-Jan-2013 and 30-Sep-2016.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03157674
Study type Observational
Source Bristol-Myers Squibb
Contact
Status Completed
Phase
Start date November 24, 2016
Completion date April 20, 2020
View Details
See also
  Status Clinical Trial Phase
Completed NCT00670553 - A Phase I Study of LBH589 (Panobinostat) in Combination With External Beam Radiotherapy for the Treatment of Prostate Cancer, Esophageal Cancer and Head and Neck Cancer Phase 1
Completed NCT03799380 - DRIHNC - Dehydration Reduction in Head & Neck Cancer N/A
Completed NCT00565721 - A Proof-of-concept Study to Assess the Ability of [18F]AH-111585 PET Imaging to Detect Tumours and Angiogenesis Phase 2
Completed NCT00796952 - Muscle Composition and Function for Swallowing in Head/Neck Cancer Patients Phase 2
Completed NCT00935961 - RAD001 (Everolimus) + Docetaxel + Cisplatin as Induction Chemotherapy in Patients With Local-Regional Advanced Head and Neck Cancer Phase 1
Recruiting NCT03065062 - Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors Phase 1
Completed NCT01268579 - Pharmacodynamic Effects of Ribavirin in Patients With Tonsil and/or Base of Tongue Squamous Cell Carcinoma N/A
Completed NCT03712397 - Nanoliposomal Irinotecan in Head & Neck and Esophagus After Prior Platinum-based Chemotherapy or Chemoradiotherapy Phase 2
Completed NCT04040166 - Carotid PET/MRI With DOTATATE in Patients Post Head and Neck Radiation Therapy N/A
Completed NCT00736619 - Weekly Nanoparticle Albumin-Bound Paclitaxel (Abraxane) + Weekly Cetuximab + Radiation Therapy (IMRT, Intensity-Modulated Radiation Therapy) in Patients With Stage III-IVB Head and Neck Squamous Cell Carcinoma (HNSCC) Phase 1
Completed NCT02375958 - PCA062 in pCAD-positive Tumors. Phase 1